Telehealth Insomnia Prescribing: What Psychiatric NPs Can Do in North Carolina

If you’re a psychiatrist or PMHNP considering telehealth for insomnia treatment, you’re probably asking: Can I legally prescribe sleep medications remotely? What are the state rules? And is this actually a viable way to build my practice?

Short answer: Yes, you can prescribe insomnia medications via telehealth in 2026 — including controlled substances like Ambien (zolpidem) — but the rules vary dramatically by state, especially for nurse practitioners. And while treating insomnia remotely offers real clinical and business advantages, understanding the regulatory landscape is critical before you start seeing patients.

This guide walks through everything you need to know: scope of practice by provider type, state-by-state prescribing rules, federal telehealth regulations for controlled substances, reimbursement, and how platforms like Klarity Health simplify the entire workflow.

Can You Prescribe Insomnia Medications via Telehealth? The Short Version

For Psychiatrists (MD/DO): You have full prescribing authority in all 50 states for insomnia medications, including Schedule IV controlled substances (zolpidem, eszopiclone, temazepam), as long as you’re licensed in the state where the patient is located. No physician supervision required. Current federal rules allow you to prescribe controlled substances via telehealth without an initial in-person visit — this flexibility has been extended through December 31, 2025, and is expected to continue in some form.

For PMHNPs: Your ability to independently prescribe insomnia medications depends entirely on your state’s scope of practice laws:

• Full Practice States (27 states including California*, New York*, Illinois*): Experienced PMHNPs can evaluate, diagnose, and prescribe independently — no physician oversight needed.
• Reduced Practice States: You need a collaborative agreement with a physician but can still prescribe within defined protocols.
• Restricted Practice States (Texas, Florida, Pennsylvania): You must have active physician supervision, often with monthly chart reviews or prescriptive authority agreements. In Texas, you can prescribe Schedule III-V drugs (which includes most insomnia meds) but not Schedule II. Florida excludes psychiatric NPs from its autonomous practice law entirely.

*With experience requirements met (3,600 hours in NY, transitional pathway in CA, 4,000 hours in IL).

The bottom line: Psychiatrists face minimal barriers to tele-prescribing insomnia medications. PMHNPs need to understand their state’s rules — and in restrictive states, may need help securing a supervising physician relationship (which platforms like Klarity can facilitate).

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Why Insomnia Treatment via Telehealth Makes Sense

Insomnia is one of the most common complaints in psychiatric practice, and it’s particularly well-suited to telehealth for several reasons:

1. Short, Focused Visits Work Well Remotely
Medication management for insomnia typically involves 15-30 minute follow-ups to assess efficacy, monitor side effects, and adjust dosing. These visits translate seamlessly to video — no physical exam needed beyond observing the patient’s alertness and affect. You can bill standard E/M codes (99213 for ~20 min, 99214 for ~30 min) and get reimbursed around $95-125 per visit under Medicare rates, with private insurance often paying at parity.

2. Patients Prefer Convenience for Sleep Issues
Many insomnia patients are working professionals or parents who can’t take time off for daytime appointments. Evening or weekend telehealth slots dramatically improve access and reduce no-shows. Plus, seeing a patient in their actual sleep environment via video can yield clinical insights (bedroom setup, lighting, noise levels) that you’d never get in an office.

3. High Demand, Low Provider Supply
The shortage of psychiatric prescribers nationwide means patients often wait months for an appointment. Telehealth lets you reach underserved areas (rural Texas, upstate New York, central Pennsylvania) without relocating, and platforms that pre-screen and match patients to your availability eliminate the cold-start problem of building a practice from scratch.

4. Regulatory Environment Is Favorable (For Now)
Federal telemedicine flexibilities for controlled substances — initially a pandemic measure — have been extended through at least the end of 2025. This means you can initiate a new patient on zolpidem via video without ever seeing them in person, which was previously prohibited under the Ryan Haight Act. While the DEA will eventually finalize new rules, the trend is toward maintaining telehealth access for mental health.

Federal Rules: Prescribing Controlled Substances via Telehealth

Most insomnia medications are Schedule IV controlled substances — this includes zolpidem (Ambien), eszopiclone (Lunesta), temazepam (Restoril), and non-benzodiazepine hypnotics. Here’s what you need to know about federal prescribing rules:

Current Flexibilities (Through December 31, 2025)

The DEA has repeatedly extended temporary rules allowing providers to prescribe Schedule III-V controlled substances via telemedicine without a prior in-person evaluation. This means:

• You can conduct an initial video visit with a new insomnia patient and e-prescribe zolpidem the same day.
• Follow-up visits for refills can also be entirely virtual.
• Audio-visual (video) telemedicine is required — audio-only phone calls don’t meet the standard for initiating controlled substances in most cases.

These flexibilities were originally set to expire multiple times but have been extended to give the DEA time to finalize permanent telemedicine prescribing regulations. The extension runs through December 31, 2025, and industry groups are lobbying to make these rules permanent for mental health prescribing.

What Happens After 2025?

The DEA is expected to publish a final rule that will either:

1. Make current flexibilities permanent for behavioral health conditions (including insomnia), or
2. Require at least one in-person visit within a certain timeframe (e.g., every 6-12 months) for patients on long-term controlled substances, or
3. Create a special telemedicine DEA registration for providers who prescribe controlled substances exclusively via telehealth.

Most experts anticipate option 1 or 2, given the demonstrated safety and effectiveness of tele-psychiatry during COVID-19. Regardless, you should stay updated on DEA announcements — but for now, tele-prescribing insomnia meds is fully legal nationwide.

Prescription Drug Monitoring Programs (PDMPs)

Nearly every state requires you to check the state PDMP before prescribing controlled substances. For example:

• Texas mandates PDMP checks for benzodiazepines, opioids, barbiturates, and carisoprodol.
• New York requires checking the I-STOP database for every Schedule II-IV prescription.
• California requires registration with CURES and checking it at least every four months for patients on controlled substances.

If you’re practicing via telehealth across multiple states, you’ll need access to each state’s PDMP system. This is a workflow consideration but not a blocker — most telehealth platforms provide guidance on registration, and many states now have interstate PDMP data sharing.

State-by-State Breakdown: Where Can You Practice?

Licensure Requirement

You must be licensed in the state where the patient is physically located during the telehealth visit. Telemedicine does not bypass state licensing requirements. Some states offer pathways to ease this:

• Interstate Medical Licensure Compact (IMLC): Physicians in compact states (including Texas and Illinois among your priority states) can apply for expedited licensure in other compact states. California, New York, and Florida are not IMLC members, so separate applications are required.
• Florida Telehealth Registration: Out-of-state physicians and NPs can register as telehealth providers in Florida without full licensure, provided they hold an unrestricted license elsewhere. This allows treating Florida patients remotely.
• APRN Compact: Not yet operational as of 2026, but legislation is advancing. For now, PMHNPs need individual state licenses.

Scope of Practice: Psychiatrists vs PMHNPs

PMHNP Scope of Practice: Your State Matters

Full Practice States (27 States + DC)

In these states, experienced PMHNPs can practice independently — evaluate patients, diagnose insomnia, and prescribe Schedule IV sleep medications without physician oversight:

• California: After completing a supervised transition period (3 years as a ‘103 NP’ working in a physician group), PMHNPs can become ‘104 NPs’ with full independent authority as of 2026. This includes prescribing controlled substances for psychiatric conditions like insomnia.

• New York: PMHNPs with 3,600+ hours of experience (roughly 2 years full-time) can practice independently without a collaborative agreement. Less experienced NPs still need a written protocol with a physician, but day-to-day supervision isn’t required.

• Illinois: After 4,000 hours of practice under a collaborative agreement plus 250 hours of continuing education, Illinois NPs can apply for Full Practice Authority, allowing independent prescribing including controlled substances (with some consultation requirements for Schedule II beyond 30 days).

What this means for you: If you’re in a full practice state and meet the experience threshold, you can join a telehealth platform like Klarity and start seeing insomnia patients immediately — no need to find a supervising physician.

Reduced Practice States

You can prescribe insomnia medications but need a formal collaborative agreement with a physician. The physician doesn’t supervise day-to-day but serves as a consultant and co-signer on protocols:

• New York (for new NPs): Under 3,600 hours requires a written collaborative agreement.
• Illinois (pre-FPA): Collaboration agreement required until you log 4,000 hours and qualify for independent status.

What this means for you: You’ll need a supervising physician on paper. Many telehealth companies can connect you with a collaborating physician or employ one to fulfill this role, so it’s not a dealbreaker — just an extra step.

Restricted Practice States

These states impose significant oversight requirements for PMHNPs:

Texas:

• Must have a Prescriptive Authority Agreement with a Texas physician.
• Agreement must include protocols for the drugs you prescribe and requires monthly quality assurance meetings and periodic chart reviews.
• NPs can prescribe Schedule III-V controlled substances (which includes zolpidem, eszopiclone, temazepam) under delegation.
• Cannot prescribe Schedule II drugs (like certain stimulants) in outpatient settings — only in hospitals or hospice.

Florida:

• Psychiatric NPs are excluded from Florida’s autonomous practice law (only primary care NPs in underserved areas can practice independently).
• Must have a physician supervision agreement and protocol filed with the Board of Nursing.
• NPs are limited to a 7-day supply of Schedule II controlled substances initially (rarely relevant for insomnia, but matters for ADHD comorbidity).
• Only psychiatric-certified NPs can prescribe psychiatric controlled substances to minors.

Pennsylvania:

• Requires a collaborative agreement with two physicians (not just one).
• NPs cannot prescribe more than a 30-day supply of Schedule II or 90 days of Schedule III-IV without physician reevaluation.
• This means if you prescribe zolpidem (Schedule IV) for chronic insomnia, after three months you’d need the supervising physician to review and approve continuation.

What this means for you: Practicing via telehealth in these states as an NP requires coordinating with a supervising physician. Platforms that employ or contract with physicians to fulfill this role can make it workable, but you’ll have less autonomy than in full practice states.

State-by-State Requirements Table

Reimbursement: Will You Get Paid?

One of the biggest concerns for providers considering telehealth is whether insurance will cover virtual visits — and at what rate.

Telehealth Parity Laws

As of 2025, 24 states plus DC have enacted laws requiring private insurers to pay for telehealth services at the same rate as in-person visits. Among your priority states:

• California: Payment parity mandated.
• Illinois: Payment parity mandated by 2021 law (permanent).
• New York: Telehealth coverage required; most insurers pay at parity voluntarily to meet network adequacy.
• Texas, Florida, Pennsylvania: Coverage required but not always explicit parity; however, most major insurers reimburse tele-mental health comparably due to market demand.

Medicare

Medicare covers tele-mental health services nationwide and reimburses at the same rate as in-person visits. Congress has repeatedly extended telehealth flexibilities, and tele-psychiatry is widely expected to remain permanently covered. Medicare does have a proposed rule requiring an in-person visit within 6 months for ongoing telehealth mental health treatment, but enforcement has been delayed through 2024 and may be waived for psychiatric care.

Typical Payment Rates

For a medication management visit (no therapy), you’d typically bill:

• CPT 99213 (20-minute established patient visit): ~$95 national average (Medicare 2026 rate).
• CPT 99214 (30-minute visit): ~$125 national average.

Private insurers often pay similar or higher rates. If you’re in a state with payment parity, you get the same reimbursement whether the visit is video or in-person.

Cash-pay telehealth visits typically range $75-150 for a 30-minute session, which aligns with insurance reimbursement and can be attractive for patients without coverage or high deductibles.

Clinical Workflow: How Insomnia Treatment via Telehealth Actually Works

Initial Evaluation (30-45 minutes)

• History: Gather sleep history (onset, duration, frequency of insomnia), review sleep hygiene, assess for comorbid psychiatric conditions (depression, anxiety, PTSD), and screen for medical causes (sleep apnea, restless legs syndrome, chronic pain).
• Assessment Tools: Many providers use validated questionnaires like the Insomnia Severity Index (ISI) or have patients complete a two-week sleep diary before the visit.
• Diagnosis: DSM-5 insomnia disorder criteria or adjustment insomnia.
• Treatment Plan: Discuss behavioral interventions (CBT-I as first-line) and pharmacotherapy options. If medication is indicated, review risks/benefits, obtain consent, and e-prescribe.

Coding: Initial visit is typically 99204 or 99205 depending on complexity (~$150-200 reimbursement).

Follow-Up Visits (15-30 minutes every 2-4 weeks initially, then monthly)

• Check efficacy: Is sleep latency and duration improving?
• Monitor side effects: Next-day drowsiness, sleep-walking, tolerance, dependence risk.
• Adjust dosing or switch medications if needed.
• Reinforce sleep hygiene and coordinate referral to CBT-I if not already done.

Coding: 99213 or 99214 (~$95-125).

PDMP Checks

Before prescribing any controlled substance (and periodically thereafter), check your state’s PDMP to ensure the patient isn’t receiving overlapping prescriptions from other providers.

E-Prescribing

All controlled substance prescriptions must be sent electronically (federal requirement in most states). Use a DEA-compliant e-prescribing system (most telehealth platforms include this).

Documentation

Document that the visit was conducted via telehealth, the patient’s location, informed consent for telemedicine, and clinical rationale for prescribing. States like Texas and Florida have specific telehealth documentation standards — check your state board guidance.

Medications You’ll Commonly Prescribe

First-line recommendation: Try behavioral interventions (CBT-I) before or alongside medication. For pharmacotherapy, start with non-benzodiazepine hypnotics (zolpidem, eszopiclone) or trazodone depending on comorbidities. Reserve benzodiazepines for patients who’ve failed other options.

How Platforms Like Klarity Health Solve the Patient Acquisition Problem

Building a telehealth practice from scratch sounds appealing — set your own schedule, work from home, reach underserved patients — but there’s a massive hidden cost most providers don’t anticipate: patient acquisition.

The Reality of DIY Marketing

Let’s say you decide to build your own telehealth practice. You’ll need to:

1. Build a website and optimize it for SEO (search engine optimization) so patients searching ‘online psychiatrist for insomnia in Texas’ find you. This takes 6-12 months of consistent content creation and link building before you see meaningful traffic.

2. Run Google Ads for keywords like ‘psychiatrist for insomnia near me.’ Mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ after accounting for click costs, ad optimization, and no-shows.

3. List on directories like Psychology Today, Zocdoc, or Healthgrades. These charge monthly subscription fees ($100-300/mo) and per-booking fees (Zocdoc charges $35-100+ per new patient). You’re competing with hundreds of other providers on the same page, and conversion rates are low.

4. Hire staff to handle lead follow-up, appointment scheduling, insurance verification, and no-show management. Most solo providers underestimate this time sink — you’ll spend hours each week on admin instead of seeing patients.

When you add it all up — agency/consultant fees, ad spend, software subscriptions, staff time, wasted spend on campaigns that don’t convert — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient. And that’s if you have the expertise and patience to execute well. Most providers don’t.

Why Klarity’s Model Makes Economic Sense

Klarity Health uses a pay-per-appointment model similar to Zocdoc, but with a key difference: you’re getting pre-qualified, pre-matched patients who are ready to book.

Here’s how it works:

• No upfront marketing spend or monthly subscription fees. You don’t pay until a patient actually books with you.
• Patients are matched to your specialty and availability. Klarity’s intake process screens for insomnia, prescribing needs, insurance coverage, and state location, so you’re not wasting time on unqualified leads.
• Built-in telehealth infrastructure. No need to pay for a separate video platform, EHR integration, or e-prescribing software — it’s included.
• Both insurance and cash-pay patient flow. You decide whether to accept insurance, set cash rates, or both.
• You control your schedule. Only pay when you see patients. No minimum patient volume requirements.

The Math:

Let’s say Klarity charges a standard listing fee per new patient lead (industry norm is around $50-150 depending on specialty and insurance vs cash-pay). Compare that to spending $3,000-5,000/month on marketing with uncertain results:

• Klarity model: See 20 new patients/month → pay $1,000-3,000 in listing fees → generate $15,000-25,000 in revenue (assuming $125 avg per visit x 6-10 visits per patient over treatment course) = guaranteed positive ROI from month one.

• DIY marketing: Spend $3,000-5,000/month on ads, SEO, directories → wait 3-6 months to see results → maybe book 10-15 patients → break even or lose money in year one while you optimize.

For most providers, especially those starting out or scaling beyond their current patient base, a platform that handles patient acquisition removes the risk entirely. You’re guaranteed ROI because you only pay when a qualified patient books with you.

What About Building Your Own Practice Long-Term?

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience to invest 12-18 months building organic traffic and refining paid campaigns. But that’s a gamble. Klarity lets you start seeing patients immediately, generate revenue from day one, and build your telehealth practice without the startup risk.

And here’s the thing: you can do both. Use Klarity to fill your schedule while you build out your own marketing in parallel. Once your own patient flow is consistent, you can reduce reliance on the platform. But in the meantime, you’re not leaving money on the table waiting for SEO to kick in.

FAQs: Prescribing Insomnia Medications via Telehealth

Can I prescribe Ambien (zolpidem) via telehealth for a new patient?

Yes, as long as you’re licensed in the state where the patient is located and comply with federal and state regulations. Current DEA rules allow prescribing Schedule IV controlled substances (including zolpidem) via telemedicine without a prior in-person visit, through at least December 31, 2025. You must conduct a video evaluation (audio-only is insufficient for initiating controlled substances), check the state PDMP, and document the encounter appropriately.

Do I need a supervising physician as a PMHNP to prescribe insomnia medications via telehealth?

It depends on your state. In full practice states (like California, New York after 3,600 hours, or Illinois after 4,000 hours), you can prescribe independently. In reduced practice states, you need a collaborative agreement but can still prescribe within defined protocols. In restricted states (Texas, Florida, Pennsylvania), you need active physician oversight, which may include monthly chart reviews or prescriptive authority agreements. Platforms like Klarity can help connect you with supervising physicians if required in your state.

Will insurance reimburse telehealth visits for insomnia?

Yes. Most private insurers now cover telehealth for mental health services, and 24 states have enacted payment parity laws requiring the same reimbursement as in-person visits. Medicare also covers tele-psychiatry at parity rates. You can bill standard E/M codes (99213, 99214) for medication management visits and expect reimbursement around $95-125 per visit on average.

What if the DEA changes the rules after 2025?

The DEA is expected to finalize permanent telemedicine prescribing regulations, which will likely maintain access for mental health conditions given the demonstrated success during COVID-19. Worst-case scenario, you might need to arrange periodic in-person visits (e.g., once every 6-12 months) for patients on long-term controlled substances. Stay updated on DEA announcements and platform policy updates — most telehealth companies will adjust workflows to remain compliant.

Can I treat insomnia patients across multiple states?

Yes, but you must be licensed in every state where your patients are located. Physicians in Interstate Medical Licensure Compact (IMLC) states can apply for expedited multi-state licensure. PMHNPs need individual state licenses for now, though an APRN Compact is in development. Some states like Florida offer special telehealth registration for out-of-state providers.

What’s the best medication for chronic insomnia?

First-line treatment is cognitive behavioral therapy for insomnia (CBT-I), which has better long-term outcomes than medication and no dependence risk. For pharmacotherapy, non-benzodiazepine hypnotics (zolpidem, eszopiclone) are most commonly used for short-term or intermittent use. For patients with comorbid depression or anxiety, trazodone or low-dose doxepin may be preferable. Newer agents like suvorexant (orexin receptor antagonist) have lower dependence risk but are expensive and often require prior authorization. Always start with the lowest effective dose and plan for periodic reassessment to avoid long-term dependence.

How do I handle patients who request higher doses or show signs of dependence?

This is a common challenge with insomnia medications. Best practices:

• Set expectations upfront that sleep medications are typically short-term (4-12 weeks) and taper off as behavioral interventions take effect.
• Use sleep diaries or wearable data to objectively track improvement (or lack thereof) rather than relying solely on patient report.
• If tolerance develops, consider switching to a different class (e.g., from zolpidem to trazodone) rather than dose escalation.
• Check PDMP regularly to screen for doctor-shopping or overlapping prescriptions.
• If dependence is suspected, initiate a taper plan and coordinate with addiction medicine or refer to specialized treatment if needed.
• Document all of this thoroughly — clinical reasoning, patient education, and attempts to reduce medication.

Can I coordinate with a patient’s primary care provider or sleep specialist?

Absolutely, and you should. Insomnia is often multifactorial. If you suspect sleep apnea, restless legs syndrome, or other medical causes, refer for sleep study evaluation. Many patients benefit from combined treatment (e.g., CPAP for sleep apnea plus medication for residual insomnia). With patient consent, send consultation notes to the PCP or sleep specialist and request relevant records. Some insurers reimburse interprofessional e-consults (CPT codes 99446-99449) if you’re providing formal recommendations to another provider.

Ready to Start Treating Insomnia via Telehealth?

If you’re a psychiatrist or PMHNP looking to expand your practice, telehealth insomnia care offers a compelling opportunity: high patient demand, favorable reimbursement, flexible scheduling, and the ability to serve underserved populations — all from wherever you choose to practice.

The regulatory landscape is more supportive than ever, especially for controlled substance prescribing, and platforms like Klarity Health remove the biggest barrier most providers face: patient acquisition. Instead of gambling thousands of dollars per month on marketing with uncertain results, Klarity’s pay-per-appointment model means you only pay when qualified patients book with you — guaranteed ROI from day one.

What Klarity offers providers:

• Pre-qualified patients matched to your specialty and availability (insomnia, anxiety, depression, ADHD)
• No upfront marketing costs or monthly subscription fees
• Built-in telehealth infrastructure (video platform, EHR, e-prescribing)
• Support with credentialing and state licensing coordination
• For PMHNPs in restricted states, assistance connecting with supervising physicians
• Insurance billing and collections handled (if desired), or set your own cash rates
• You control your schedule — work as much or as little as you want

Whether you’re starting a telehealth practice from scratch or looking to fill open slots in your existing schedule, Klarity gives you access to patients who need your expertise — without the startup risk and marketing headaches of going solo.

Next Steps:

• Review your state’s scope of practice and licensing requirements above
• Check that you meet any experience thresholds for independent practice (if applicable)
• If you’re in a restricted state, confirm you have or can obtain a supervising physician relationship
• Apply to join Klarity’s provider network at [join.klarityhealth.com]

The shortage of psychiatric providers isn’t going away, and insomnia is one of the fastest-growing treatment areas in telehealth. The question isn’t whether there are patients who need your help — it’s whether you’re positioned to reach them efficiently. Platforms like Klarity solve that problem so you can focus on what you do best: delivering high-quality care.

Sources and References

1. California Board of Registered Nursing – AB 890 Implementation. Independent NP Practice Pathways (updated 2024). https://www.rn.ca.gov/practice/ab890.shtml

2. Texas Medical Board – APRN Prescribing and Supervision FAQs. Prescriptive Authority Agreement Requirements (accessed Feb 2026). https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision

3. Rivkin Rounds Law Blog – New Law Allows Experienced NPs to Practice Independently in NY (April 13, 2022). [https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/](https://www

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025